Literature DB >> 27297700

Procedural Impact of a Dedicated Interventional Oncology Service Line in a National Cancer Institute Comprehensive Cancer Center.

Mary Ellen Koran1, Andrew J Lipnik2, Jennifer C Baker2, Filip Banovac2, Reed A Omary2, Daniel B Brown3.   

Abstract

PURPOSE: We tested the hypothesis that establishing a dedicated interventional oncology (IO) clinical service line would increase clinic visits and procedural volumes at a single quaternary care academic medical center.
METHODS: Two time periods were defined: July 2012 to June 2013 (pre-IO clinic) and July 2013 to June 2014 (first year of dedicated IO service). Staff was recruited, and clinic space was provided in the institution's comprehensive cancer center. Clinic visits and procedure numbers were documented using the institution's electronic medical record and billing forms. IO procedures included were transarterial chemoembolization, Y-90 radioembolization, perfusion mapping for Y-90, portal vein embolization, and bland embolization. We compared changes in clinic visit and procedure numbers using paired t tests. Changes after IO initiation were compared to 1-year changes in the Medicare 5% Limited Data Set by cross-referencing Current Procedure Terminology and International Classification of Diseases codes in 2012 and 2013.
RESULTS: Clinic visits increased from 9 to 204 (P = .003, t = 8.89, df = 3). Procedures increased from 60 to 239 (P = .018, t = 3.85, df = 4). Procedural volumes increased at least 150% for each subtype. The volumes in the 5% Limited Data Set did not change significantly over the 2-year period (443 to 385, P > .05).
CONCLUSIONS: The establishment of a dedicated IO service significantly increased clinic visits and procedural volumes. National trends were unchanged, suggesting that the impact of our program was not part of a sudden increase of IO procedures.
Copyright © 2016 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Interventional radiology; chemoembolization; portal vein embolization; practice development; radioembolization

Mesh:

Year:  2016        PMID: 27297700      PMCID: PMC5012920          DOI: 10.1016/j.jacr.2016.04.033

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  29 in total

Review 1.  Developing a comprehensive diagnostic and interventional nephrology program at an academic center.

Authors:  Arif Asif; Patricia Byers; Cristovao F Vieira; David Roth
Journal:  Am J Kidney Dis       Date:  2003-08       Impact factor: 8.860

2.  Improving inferior vena cava filter retrieval rates: impact of a dedicated inferior vena cava filter clinic.

Authors:  Jeet Minocha; Ibrahim Idakoji; Ahsun Riaz; Jennifer Karp; Ramona Gupta; Howard B Chrisman; Riad Salem; Robert K Ryu; Robert J Lewandowski
Journal:  J Vasc Interv Radiol       Date:  2010-10-28       Impact factor: 3.464

Review 3.  Practice building in interventional oncology.

Authors:  Daniel B Brown; Jennifer E Gould
Journal:  Tech Vasc Interv Radiol       Date:  2006-09

Review 4.  Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough.

Authors:  G D Dodd; M C Soulen; R A Kane; T Livraghi; W R Lees; Y Yamashita; A R Gillams; O I Karahan; H Rhim
Journal:  Radiographics       Date:  2000 Jan-Feb       Impact factor: 5.333

5.  Neuroendocrine tumors, version 1.2015.

Authors:  Matthew H Kulke; Manisha H Shah; Al B Benson; Emily Bergsland; Jordan D Berlin; Lawrence S Blaszkowsky; Lyska Emerson; Paul F Engstrom; Paul Fanta; Thomas Giordano; Whitney S Goldner; Thorvardur R Halfdanarson; Martin J Heslin; Fouad Kandeel; Pamela L Kunz; Boris W Kuvshinoff; Christopher Lieu; Jeffrey F Moley; Gitonga Munene; Venu G Pillarisetty; Leonard Saltz; Julie Ann Sosa; Jonathan R Strosberg; Jean-Nicolas Vauthey; Christopher Wolfgang; James C Yao; Jennifer Burns; Deborah Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2015-01       Impact factor: 11.908

6.  Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare Beneficiaries.

Authors:  Hanna K Sanoff; YunKyung Chang; Joseph M Stavas; Til Stürmer; Jennifer Lund
Journal:  J Natl Compr Canc Netw       Date:  2015-09       Impact factor: 11.908

7.  Medicare inpatient and 90-day postdischarge adverse outcomes in carotid artery surgery.

Authors:  Donald E Fry; Michael Pine; David Locke; Agnes Reband; Zeke Torres; Gregory Pine
Journal:  Surgery       Date:  2015-07-07       Impact factor: 3.982

8.  Hepatobiliary cancers, version 2.2014.

Authors:  Al B Benson; Michael I D'Angelica; Thomas A Abrams; Chandrakanth Are; P Mark Bloomston; Daniel T Chang; Bryan M Clary; Anne M Covey; William D Ensminger; Renuka Iyer; R Kate Kelley; David Linehan; Mokenge P Malafa; Steven G Meranze; James O Park; Timothy Pawlik; James A Posey; Courtney Scaife; Tracey Schefter; Elin R Sigurdson; G Gary Tian; Jean-Nicolas Vauthey; Alan P Venook; Yun Yen; Andrew X Zhu; Karin G Hoffmann; Nicole R McMillian; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2014-08       Impact factor: 11.908

9.  The interventional radiology clinic: key ingredients for success.

Authors:  Gary P Siskin; Sandeep Bagla; Gail E Sansivero; Nancy L Mitchell
Journal:  J Vasc Interv Radiol       Date:  2004-07       Impact factor: 3.464

10.  Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases.

Authors:  Anne M Covey; Karen T Brown; William R Jarnagin; Lynn A Brody; Lawrence Schwartz; Scott Tuorto; Constantinos T Sofocleous; Michael D'Angelica; George I Getrajdman; Ronald DeMatteo; Nancy E Kemeny; Yuman Fong
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

View more
  1 in total

Review 1.  Interventional Oncology Service Development.

Authors:  Samdeep Mouli; Jennifer C Baker; Daniel B Brown
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.